A/Prof Thomas John received his medical degree from Monash University and PhD from University of Melbourne in 2008. He completed a post-doctoral fellowship with Prof F.Shepherd and Prof M. Tsao in Toronto before returning to Melbourne.
He is a member of ASCO, ESMO, IASLC, AACR, and MOGA. He is an associate editor for the Journal of Thoracic Oncology and is actively involved clinical trials and translational research in lung cancer and mesothelioma.
He was an author and investigator on several trials using Osimertinib, including the initial Phase I AURA study, AURA3, FLAURA and ADAURA.